Trilogy Capital Portfolio holdings
Top Buys
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.44M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$4.37M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$4.27M |
| 4 |
Invesco Emerging Markets Sovereign Debt ETF
PCY
|
+$3.5M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$2.31M |
Sector Composition
| 1 | Utilities | 1.14% |
| 2 | Healthcare | 0.85% |
| 3 | Consumer Staples | 0.73% |
| 4 | Communication Services | 0.55% |
| 5 | Financials | 0.43% |
Similar funds
Trilogy Capital's Q3 2022 Portfolio in Review
As of Q3 2022, Trilogy Capital held 187 positions worth $1.12B, down 2.9% from $1.15B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Trilogy Capital deployed $42.2M of net new capital in Q3 2022, opening 28 new positions and adding to 108 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 63,331 shares worth $6.49M.
By sector, the portfolio is most concentrated in Utilities at 1.1% of assets, up from 1.1% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $5.44M trimmed.
- Trilogy Capital's largest Q3 2022 buy was iShares 20+ Year Treasury Bond ETF: 63,331 shares worth $6.49M.
- Trilogy Capital added most to Vanguard Intermediate-Term Bond ETF in Q3 2022, an estimated $7.17M increase.
- Trilogy Capital's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.44M.
- Trilogy Capital fully exited JPMorgan Ultra-Short Income ETF in Q3 2022, selling an estimated $2.31M.
- Trilogy Capital's ten largest holdings make up 51% of its $1.12B portfolio in Q3 2022.
- Trilogy Capital opened 28 new positions and closed 10 in Q3 2022.
- Trilogy Capital's portfolio value fell 2.9% quarter-over-quarter to $1.12B.
Based on Trilogy Capital's 13F filing for Q3 2022, filed 21 Oct 2022.